Palantir co-founder Joe Lonsdale is calling for a tech-led overhaul of the FDA through a “special forces” AI team to accelerate drug approvals, warning that outdated systems are allowing China to surpass the U.S. in biotech innovation.
Palantir co-founder Joe Lonsdale is calling for a tech-led overhaul of the FDA through a “special forces” AI team to accelerate drug approvals, warning that outdated systems are allowing China to surpass the U.S. in biotech innovation.
Copyright © Louis Velazquez. All Rights Reserved.